The crystal structure is shown in the gure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. . 
Experimental details
All H atoms were placed in calculated positions and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C).
Discussion
The incorporation of an adamantyl group positively modulates the therapeutic index of several compounds through various mechanisms [1, 2] . Several adamantane derivatives have long been known for their antiviral activity against the in uenza A [3] [4] [5] [6] , human immunode ciency (HIV) [7] [8] [9] and herpes simplex [10] viruses. Several adamantane-based drugs are currently used as useful medications for the control of central nervous disorders [10] [11] [12] [13] . In addition, potent antimicrobial [14] [15] [16] , anticancer [17, 18] , anti-in ammatory [19] [20] [21] and hypoglycemic [22] activities were reported for numerous adamantane-based derivatives. Isothiourea derivatives were also recognized as a structural motif of particular value in medicinal chemistry possessing diverse biological activities [23, 24] . In the present study, we report the synthesis and the X-ray structure analysis of the title adamantane-isothiourea hybrid molecule as potential bioactive agent. The asymmetric unit of the title compound contains one independent molecule. The bond length of N1-C11 is 1.2640(19) Å, which is typical for a N = C double bond and the con guration around this double bond is cis. The piperazine ring of the phenylpiperazine adopts a chair conformation and the phenyl ring occupies an equatorial orientation. The molecules pack in the crystal structure without any signicant intermolecular hydrogen bonds.
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